tiprankstipranks
Advertisement
Advertisement
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
PremiumCompany AnnouncementsKYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
3M ago
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
Premium
Company Announcements
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
5M ago
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
Premium
Company Announcements
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
6M ago
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
PremiumCompany AnnouncementsKYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
11M ago
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
Premium
Company Announcements
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
11M ago
KYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
Premium
Company Announcements
KYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
11M ago
KYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
PremiumCompany AnnouncementsKYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
1y ago
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
Premium
Company Announcements
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
1y ago
KYORIN Strikes Deal with Bayer for OSA Treatment
Premium
Company Announcements
KYORIN Strikes Deal with Bayer for OSA Treatment
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100